−0.6749USD
−27.26 MUSD
3.79 KUSD
41.76 M
About Eyenovia, Inc.
Sector
CEO
Michael M. Rowe
Headquarters
New York
Website
Employees (FY)
57
Founded
2014
ISIN
US30234E1047
FIGI
BBG00JKZRCH4
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of EYEN is 0.5706 USD — it has increased by 7.48% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Eyenovia, Inc. stocks are traded under the ticker EYEN.
Eyenovia, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
EYEN stock is 13.46% volatile and has beta coefficient of 3.29. Check out the list of the most volatile stocks — is Eyenovia, Inc. there?
One year price forecast for Eyenovia, Inc. has a max estimate of 12.0000 USD and a min estimate of 5.0000 USD.
EYEN earnings for the last quarter are −0.18 USD per share, whereas the estimation was −0.18 USD resulting in a 0.08% surprise. The estimated earnings for the next quarter are −0.17 USD per share. See more details about Eyenovia, Inc. earnings.
Eyenovia, Inc. revenue for the last quarter amounts to 1.20 M USD despite the estimated figure of 155.13 K USD. In the next quarter revenue is expected to reach 247.25 K USD.
Yes, you can track Eyenovia, Inc. financials in yearly and quarterly reports right on TradingView.
EYEN stock has fallen by 6.46% compared to the previous week, the month change is a 53.61% fall, over the last year Eyenovia, Inc. has showed a 87.23% decrease.
EYEN net income for the last quarter is −7.97 M USD, while the quarter before that showed −7.34 M USD of net income which accounts for −8.56% change. Track more Eyenovia, Inc. financial stats to get the full picture.
Today Eyenovia, Inc. has the market capitalization of 26.87 M, it has decreased by 24.31% over the last week.
No, EYEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EYEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eyenovia, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 57.00 employees. See our rating of the largest employees — is Eyenovia, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Eyenovia, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Eyenovia, Inc. stock shows the sell signal. See more of Eyenovia, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Eyenovia, Inc. future price: according to them, EYEN price has a max estimate of 12.00 USD and a min estimate of 5.00 USD. Read a more detailed Eyenovia, Inc. forecast: see what analysts think of Eyenovia, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Eyenovia, Inc. EBITDA is −24.34 M USD, and current EBITDA margin is −650.20 K%. See more stats in Eyenovia, Inc. financial statements.